Capital Analysts LLC’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28K Hold
1,320
﹤0.01% 1054
2025
Q4
$28K Hold
1,320
﹤0.01% 1037
2025
Q3
$28K Hold
1,320
﹤0.01% 1001
2025
Q2
$28K Hold
1,320
﹤0.01% 932
2025
Q1
$27K Hold
1,320
﹤0.01% 925
2024
Q4
$27K Hold
1,320
﹤0.01% 872
2024
Q3
$28K Hold
1,320
﹤0.01% 839
2024
Q2
$27K Hold
1,320
﹤0.01% 811
2024
Q1
$27K Hold
1,320
﹤0.01% 769
2023
Q4
$27K Buy
+1,320
New +$26K ﹤0.01% 762

Other funds holding IBDW

Capital Analysts LLC's IBDW Position: Q1 2026 in Review

Capital Analysts LLC held its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) position steady in Q1 2026 at 1,320 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Capital Analysts LLC first reported a position in IBDW in Q4 2023 and has held it in 10 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Capital Analysts LLC held 1,320 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $28K as of Q1 2026.
  • Capital Analysts LLC left its iShares iBonds Dec 2031 Term Corporate ETF share count unchanged in Q1 2026.
  • iShares iBonds Dec 2031 Term Corporate ETF made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #1054 holding.
  • Capital Analysts LLC first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.